Publications

5674 Results

Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the leukemia and lymphoma molecular profiling project

Authors
L Rimsza;RA Roberts;TP MIller;JM Unger;M LeBlanc;R Braziel;DD Weisenburger;WC Chan;K Muller-Hermelink;ES Jaffe;RD Gascoyne;E Campo;D Fuchs;CM Spier;RI FIsher;J Delabie;A Rosenwald;LM Staudt;T Grogan
Journal / Conference
Blood 103(11):4251-4258
Year
2004
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

A Southwest Oncology Group randomized phase II study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer

Authors
GH Lyman;SJ Green;PM Ravdin;CE Geyer Jr;CA Russell;SP Balcerzak;GT Budd;S Martino
Journal / Conference
Breast Cancer Research and Treatment 85:143-150
Year
2004
Research Committee(s)
Breast
Study Number(s)
SWOG-9520

Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713

Authors
MJ Edelman;K Chansky;LE Gaspar;B Leigh;GR Weiss;SA Taylor;J Crowley;R Livingston;DR Gandara
Journal / Conference
Journal of Clinical Oncology 22(1):127-132
Year
2004
Research Committee(s)
Lung
Study Number(s)
S9713

Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel

Authors
MJ Edelman;JI Clark;K Chansky;K Albain;N Bhoopalam;GR Weiss;JK Giguere;K Kelly;J Crowley;DR Gandara
Journal / Conference
Clinical Cancer Research 10:5022-5026
Year
2004
Research Committee(s)
Lung
Study Number(s)
S9806

Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in Southwest Oncology Group chemotherapy trials

Authors
BGM Durie;J Jacobson;B Barlogie;J Crowley
Journal / Conference
Journal of Clinical Oncology 22(10):1857-1863
Year
2004
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8229/30, SWOG-8624, SWOG-9028, SWOG-9210

SWOG 0101: Evaluation of gemcitabine and irinotecan in esophageal cancer

Authors
SK Williamson;S McCoy;JL Abbruzzese
Journal / Conference
American Society of Clinical Oncology Gastrointestinal Cancers Symposium #25
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
S0101

A phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study

Authors
RP Whitehead;J Moon;SS McCachren;EM Hersh;W Samlowski;JT Beck;NS Tchekmedyian;VK Sondak
Journal / Conference
Cancer 100(8):1699-1704
Year
2004
Research Committee(s)
Melanoma
Study Number(s)
S9804

Quality of Life (QOL) and pain in advanced stage prostate cancer: impact of missing data on evaluating palliation in SWOG 9916

Authors
DL Berry;CM Moinpour;C Jiang;LV Vinson;PN Lara;S Lanier;ME Taplin;PA Burch;DP Petrylak;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 23:400, (#4579)
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
S9916

Three-month change in PSA as a surrogate endpoint for mortality in advanced hormone-refractory prostate cancer (HRPC): data from Southwest Oncology Group Study S9916

Authors
ED Crawford;DK Pauler;CM Tangen;MHA Hussain;EJ Small;ME Taplin;PA Burch;GF Greene;PN Lara Jr;DP Petrylak
Journal / Conference
Proc of the American Society of Clinical Oncology 23:382 (#4505)
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
S9916

SWOG 99-16: randomized phase III trial of docetaxel (D)/estramustine (E) versus mitoxantrone (M)/prednisone (p) in men with androgen-independent prostate cancer (AIPCA)

Authors
DP Petrylak;C Tangen;M Hussain;PN Lara;J Jones;M Talpin;P Burch;G Greene;E Small;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 23:2 (#3)
Year
2004
Research Committee(s)
Genitourinary
Study Number(s)
S9916